Preclinical Assessment of Simultaneous Targeting of Epidermal Growth Factor Receptor (ERBB1) and ERBB2 as a Strategy for Cholangiocarcinoma Therapy†,‡

Zichen Zhang(Virginia Commonwealth University Medical Center), Alphonse E. Sirica(GTx (United States))

Hepatology

May 23, 2010

10.1002/hep.23773

Cited by 44

Related Papers

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

|Hepatology|2004|120

A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡

|Hepatology|2007|83

Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model

|American Journal Of Pathology|2017|22